A stagnation of the local activity
During Q2 2016, Unimed’s sales increased by 11.4% to TND16.98m against TND15.24m in Q2 2015. This growth has been pulled up by Pharmaceutical sales (+10.5% yoy), Export sales (+34.5% yoy) as well as export outsourcing (+13.2% yoy). Thus, the company’s revenues in H1 2016 reached TND31.79m, an increase of 6.3% compared to H1 2015. This growth has been slowed down by Hospitals sales which declined by 5.3% to TND10.03m. The production volume rose by only 1.2% to 89.9 million units.
AlphaMena is the MENA stocks leader in independent equity research, covering 142. MENA securities spanning across 19 sectors and 8 countries relaying on a team of 11 analysts. The breadth of coverage allows AlphaMena to formulate a coherent view on markets, sectors and to highlight the best investments in Mena zone using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.